Christelle Mabilat

Title: Christelle Mabilat: Innovator in Gene Therapy

Introduction

Christelle Mabilat is a prominent inventor based in Corbeil-Essonnes, France. She has made significant contributions to the field of gene therapy, particularly in the treatment of tumors. Her innovative approach focuses on utilizing adenovirus vectors to deliver anti-angiogenic factors directly to tumor cells.

Latest Patents

Mabilat holds a patent for her invention titled "Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors." This patent describes a method for introducing a gene encoding an anti-angiogenic factor into tumor cells using a defective adenovirus vector. The invention aims to inhibit tumor growth and metastasis by delivering specific viral vectors that express proteins capable of inducing apoptosis in tumor cells. Her work has shown promising results in inhibiting neovascularization and tumorigenicity.

Career Highlights

Christelle Mabilat is associated with Gencell Sas, where she continues to advance her research in gene therapy. Her dedication to innovation in this field has positioned her as a key figure in the development of new therapeutic strategies for cancer treatment.

Collaborations

Mabilat has collaborated with notable colleagues, including Hong Li and He Lu, who share her commitment to advancing medical research and developing effective treatments for tumors.

Conclusion

Christelle Mabilat's work in gene therapy represents a significant advancement in the fight against cancer. Her innovative approaches and dedication to research continue to inspire progress in the medical field.